Corporate
News coverage on GSK
August 16, 2026
GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar | Industry News - Business Standard
Source : Business Standard
August 14, 2026
GSK India Portfolio Pivot Gathers Pace, Blenrep Poised As Oncology 'Arrowhead'
Source : SCRIP Commercial News & Insights
Media articles: 2025 and earlier
2025
December 5, 2025
GSK India plans big 'reinvention', MD Bhushan Akshikar reveals
Source : The Economic Times
September 9, 2025
GSK working on affordable vaccines for neglected diseases, partnership with India key: Jamila Louahed
Source : Moneycontrol
August 26, 2025
GSK Pharma re-enters oncology market
Source : The Times of India
August 26, 2025
GSK Enters India’s Oncology Space With Jemperli & Zejula For Women’s Cancers
Source : BW Healthcare World
August 26, 2025
Why Jemperli and Zejula will be key assets in GSK’s India oncology portfolio?
Source : Business Today
August 26, 2025
GSK India Oncology Second Innings: Can Jemperli, Zejula Set The Pace?
Source : SCRIP Citeline Commercial
August 25, 2025
GSK enters into oncology segment; launches therapies for gynaecological cancers
Source : Press Trust Of India
August 25, 2025
GSK re-enters India's cancer drug market
Source : The Economic Times
August 25, 2025
GSK India re-enters oncology segment with launch of Jemperli and Zejula
Source : Business Standard
August 25, 2025
GSK re-enters cancer drugs segment with two gynaecology drugs
Source : The Hindu BusinessLine
August 25, 2025
GSK To Launch Jemperli & Zejula Drugs In India To Treat Gynaecological Cancers
Source : CNBC TV18 - YouTube
August 25, 2025
GSK re-enters India's oncology market with Jemperli and Zejula, unveils tiered pricing and patient support program
Source : Moneycontrol
August 25, 2025
GSK introduces Jemperli and Zejula in India to expand oncology portfolio
Source : Express Pharma
August 25, 2025
GSK Enters Oncology in India with Jemperli and Zejula
Source : Sakshi
August 25, 2025
जीएसके ने ‘ऑन्कोलॉजी’ क्षेत्र में किया प्रवेश; स्त्री रोग संबंधी कैंसर के लिए उपचार शुरू किया
Source : ThePrint Hindi
February 27, 2025
AstraZeneca, Bayer, Eli Lilly: Why global pharma giants are betting big on India’s healthcare revolution
Source : Fortune India
January 4, 2025
GSK marks century in India with commemorative ₹5 stamp
Source : The Hindu BusinessLine
January 4, 2025
Released Customized My Stamp and Special Postal Cover commemorating the 100 years of GlaxoSmithKline Pharmaceuticals Ltd.
Source : X.Com
2024
News9, 18/11/2024
A Century of Care: GSK's Transformative Journey in India
The Hindu, 14/11/2024
Affordable generics will stay relevant amid a premiumisation trend: GSK's Bhushan Akshikar
Chemical Industry Digest, 14/11/2024
GSK Celebrates Hundred Years in India
The Hindu Business Line, 13/11/2024
'Reinvention, resilience critical to GSK's 100-year journey in India'
Internal, 12/11/2024
Centenary Year Front-page Advertisement
Internal, 12/11/2024
Centenary Celebration
The Times of India, 09/10/2024
GlaxoSmithKline Pharma to enter oncology market, launch adult vax
SCRIP Citeline Commercial, 23/09/2024
Building On 100 Years In India: The Next Big Things On GSK's Horizon
SCRIP Citeline Commercial, 18/09/2024
100 Years In India – GSK's Secret Sauce To Not Just Stay Relevant But Thrive
2023
The Times of India, 30/05/2023
'Anti-shingles vax a must in preventive armour of adult vaccination'
ET Brand Equity, 29/05/2023
GlaxoSmithKline and Amitabh Bachchan join forces to raise 'Shingles' awareness
Business Standard, 24/04/2023
GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD
The Hindu BusinessLine, 24/04/2023
Shingles vaccine roll-out will boost GSK’s adult vaccine kitty
2022
The Times of India, 10/12/2022
GSK Pharma bets on growing adult vaccine market
The Economic Times, 03/09/2022
GSK's pharma brands doing well: India MD
The Times of India, 29/04/2022
From childhood to adulthood: The need for life course vaccination
The Economic Times, 26/04/2022
GSK launches once daily, single inhaler-triple therapy for COPD patients
Financial Express, 26/04/2022
GSK launches single-inhaler triple therapy in India for COPD patients
ETBrandEquity, 24/02/2022
GSK and MS Dhoni team up for 6-in-1 vaccination awareness campaign
Scrip, 28/01/2022
GSK Pharma India chief on pandemic decisions, refreshing the portfolio
2021
Economic Times HealthWorld, 25/09/2021
Severe Asthma: The Implications and Effective Management
Economic Times HealthWorld, 05/05/2021
GSK Pharma India’s Dr. Markandeywar, Dr. Sharma and Dr. Gvalani uncover asthma misconceptions
2020
The Economic Times, 15/10/2020
The pandemic fast forwarded our digital journey: Sridhar Venkatesh, Managing Director, India, GSK Pharmaceuticals
The Economic Times, 01/10/2020
There is a greater need now for quick results without any compromise on efficacy and patient safety : Sridhar Venkatesh, Managing Director, GSK India
Reuters, 20/06/2020
GSK in quest to be best, not first, in race for COVID-19 vaccine
CNBC TV 18, 10/06/2020
When can we expect a COVID-19 vaccine?
2018
Business Standard, 13/06/2018
